µþ°ùø»å°ì°ù³Ü³¾³¾±ð Forside ZIARCO Pharma ZIARCO Pharma Developed dermatological drugs, the lead being an H4 receptor antagonist tested in Atopic Dermatitis and Psoriasis patients. Â鶹Éç BioCapital ±õ²Ô±¹±ð²õ³Ù±ð°ù¾±²Ô²µ²õÃ¥°ù 2014 Acquired by Novartis in 2016 Lokation San Francisco, California, USA
